5 completed, 2 recruiting, 2 unknown, 1 terminated. 11 Phase 2, 4 Phase 1, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 11 | Completed 5, Recruiting 2, Unknown 2, Terminated 1, Withdrawn 1 |
| Phase 1 | 4 | Completed 2, Recruiting 1, Withdrawn 1 |
| Phase 3 | 3 | Completed 2, Unknown 1 |
Follow Urinary Retention: new trials by email Literature Review of Urinary Retention trials Research Report on Urinary Retention
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prevention of Post Operative Urinary Retention After Thoracic Surgery Trial Tamsulosin Hydrochloride, Placebo - Urinary Retention Postoperative | Phase 2 | Recruiting | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 60 | 2024-10-01 | 2024-10-28 |
| Intravesical Antifibrinolytic for Patients With Hematuria and Clot Retention Tranexamic acid - Urologic Diseases, Prostate Cancer | Phase 1 / Phase 2 | Completed | Fraser Health | 14 | 2021-03-01 | 2021-11-05 |
| Prophylactic Administration of Alpha Blockers for Prevention of Urinary Retention in Males Undergoing Inguinal Hernia Repair Under Spinal Anaesthesia. Tamsulosin, Placebo oral tablet - Inguinal Hernia, Urinary Retention | Phase 1 / Phase 2 | Completed | Georgios Koukoulis | 100 | 2020-02-01 | 2021-11-26 |
| Tamsulosin vs Placebo to Prevent Postoperative Urinary Retention in Female Pelvic Reconstructive Surgery Placebo oral capsule, Tamsulosin - Urinary Retention, Lower Urinary Tract Symptoms | Phase 2 / Phase 3 | Completed | University Hospitals Cleveland Medical Center | 132 | 2018-08-01 | 2021-11-08 |
| Post-operative Urinary Retention (POUR) Following Thoracic Surgery Tamsulosin - 1 week, Tamsulosin - 3 days - Urinary Retention | Phase 1 / Phase 2 | Recruiting | Hackensack Meridian Health | 127 | 2018-05-07 | 2026-06-11 |
| Prophylactic Tamsulosin in Prevention of Post-operative Urinary Retention in Men After Transanal Endoscopic Microsurgery Tamsulosin Hydrochloride 0.4 MG, Placebo oral capsule, Foley catheter - Urinary Retention | Phase 2 | Unknown | CHU de Quebec-Universite Laval | 158 | 2017-10-06 | 2021-05-19 |
| Thrombolysis in Ischemic Spinal Cord Stroke Intravenuse Alteplase - Motor Weakness in Two or Four Limbs, Damage in the Anterior Spinal Artery (ASA) | Phase 2 | Terminated | Rabin Medical Center | 12 | 2016-04-01 | 2019-03-28 |
| The Effect of Catheter Valve Vs. Standard Catheter Removal in Outpatients Use of catheter valve before 'trial removal of catheter', Trial removal of catheter in patients with urinary retention - Urinary Retention | Phase 2 / Phase 3 | Unknown | Medway NHS Foundation Trust | 100 | 2016-03-01 | 2016-03-28 |
| Bacterial Properties With LoFric® Catheters During Clean Intermittent Catheterization LoFric® catheters during clean intermittent catheterization - Neurogenic Bladder, Urinary Retention | Phase 1 / Phase 2 | Withdrawn | Nationwide Children's Hospital | 2011-05-06 | 2019-08-07 | |
| Botulinum Toxin A Injections in Patients With Fowler's Syndrome onabotulinumtoxinA - Urinary Retention, Fowler's Syndrome | Phase 2 / Phase 3 | Completed | University College, London | 10 | 2009-11-01 | 2015-04-29 |
| Self Management in Urinary Catheter Users Self-management of urinary catheter - Urinary Retention, Neurogenic Bladder | Phase 2 | Completed | University of Rochester | 202 | 2009-06-01 | 2012-09-18 |
Urinary Bladder, Neurogenic (2) · Chronic Disease (1) · Fowler Christmas Chapple syndrome (1) · Hematuria (1) · Hernia, Inguinal (1) · Intestinal Diseases (1) · Lower Urinary Tract Symptoms (1) · Lung Neoplasms (1) · Patient Satisfaction (1) · Pelvic Organ Prolapse (1) · Prostatic Neoplasms (1) · Urinary Bladder Neoplasms (1) · Urinary Incontinence, Stress (1) · Urologic Diseases (1)
Female Urogenital Diseases (11) · Female Urogenital Diseases and Pregnancy Complications (11) · Male Urogenital Diseases (11) · Urination Disorders (11) · Urogenital Diseases (11) · Urologic Diseases (10) · Pathological Conditions, Signs and Symptoms (5) · Signs and Symptoms (3) · Urinary Bladder Diseases (3) · Neoplasms (2) · Neoplasms by Site (2) · Nervous System Diseases (2) · Neurologic Manifestations (2) · Pathologic Processes (2) · Pathological Conditions, Anatomical (2)
Tamsulosin (5) · Blood Glucose Self-Monitoring (1) · Botulinum Toxins, Type A (1) · Self-Management (1) · Sugars (1) · Tranexamic Acid (1)
CHU de Quebec-Universite Laval (1) · Fraser Health (1) · Georgios Koukoulis (1) · Hackensack Meridian Health (1) · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1) · Medway NHS Foundation Trust (1) · Nationwide Children's Hospital (1) · Rabin Medical Center (1) · University College, London (1) · University Hospitals Cleveland Medical Center (1) · University of Rochester (1)
United States (4) · Canada (3) · Greece (1) · Israel (1) · United Kingdom (1)
Ali Abdalvand, MD (1) · Georgios D Koukoulis, MD, PhD (1) · Graham Chapman (1) · Israel Steiner, Professor (1) · Konstantinos Mpouliaris, MD (1) · Konstantinos Tepetes, MD, PHD (1) · Mary H. Wilde, RN, PhD (1) · Michael Spallone, MD (1) · Rahul Nayal (1) · Sebastien Drolet, MD FRCSC (1) · Shikohe Masood, MD (1)
PMID 11743295, PMID 15291863, PMID 25502058, PMID 26938358, PMID 33894146, PMID 39745289
R01NR010553 (1)